Babcock & Wilcox Enterprises (BW) - P/E multiplikatori

Babcock & Wilcox Enterprises - BW emitenti grafik logotipi

Babcock & Wilcox (BW) narxlar grafigi multiplikator dinamikasini aks ettiradi, u hozirda 160.90 darajasida turibdi. Biznes qarz majburiyatlari va yashil standartlarning sekin joriy etilishi bilan bog'liq tahdidlarga duch kelmoqda. Xalqaro sanksiyalar va savdo mojarolari uskunalar yetkazib berishga to'sqinlik qilib, rentabellikka salbiy ta'sir ko'rsatmoqda. Shu bilan birga, kompaniya muhandislik va dizaynni saqlab qolgan holda, korpus ishlab chiqarishni autsorsing qilish orqali yetkazib beruvchilarga bog'liqlikni minimallashtirmoqda.

BW - Babcock & Wilcox Enterprises, Inc. P/E multiplikatori 04.07.2022 - 15.11.2026 oraligʻida

babcock.com (BW) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Kompaniyaning har tomonlama tahlili:BW, Babcock & Wilcox Corp
Babcock & Wilcox original mahsuloti

Ushbu ko'rsatkich biznesning bozor qiymatining uning sof foydasi nisbati sifatida hisoblanadi va investitsiyalarning qoplanish muddatini belgilaydi. Mazkur ko'rsatkich naqd pul generatsiyasi samaradorligiga oid bozor kutganlarini o'lchaydi. Babcock & Wilcox (BW) uchun bu vodorod va uglerod tutish texnologiyalariga o'tish xarajatlarini aks ettiradi. Kompaniyaning fundamental P/E ko'paytirgichining narx dinamikasi uning transformatsiyasining haqiqiy muvaffaqiyatlari va joriy bozor baholovi o'rtasidagi farqni ochib beradi.

Raqobatdosh kompaniyalar

Berkshire (BRK-A) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati J&J (JNJ)|GE - Kapitalizatsiyaning foydaga nisbati|3m.com - Narx-foyda koeffitsiyenti|Illinois Tool Works Inc. - Narxning foydaga nisbati|IX: Narx-foyda koeffitsiyenti|DOV: Narxning foydaga nisbati|PAGP: P/E multiplikatori|Kanzhun Limited - Kompaniya qiymatining sof foydaga nisbati|LBRDA (Liberty Broadband) - P/E multiplikatori|SWX: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati CSW Industrials Corp (CSW)|GFF - Kapitalizatsiyaning foydaga nisbati|Otter Tail Corp - Narx-foyda koeffitsiyenti|BBUC (Brookfield Business Corp) - Kapitalizatsiyaning sof foydaga nisbati|PAM - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati MDU Resources|PCH: P/E multiplikatori|CSAN - Biznesning o‘zini qoplash muddati|NWL (Newell Brands Inc) - P/E multiplikatori|Narx-foyda multiplikatori BBU (Brookfield)|P/E multiplikatori KEN|Biznesning o‘zini qoplash muddati Formula Systems (1985) Ltd.|Narxning foydaga nisbati TriMas Company TRS|ZD: Narx-foyda multiplikatori|SPB - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Tiptree Inc. TIPT|sosyun.com (SOS) - Narxning foydaga nisbati|Narx-foyda multiplikatori RHLD|Narxning foydaga nisbati Compass Diversified Holdings|Kapitalizatsiyaning foydaga nisbati Valhi Inc VHI|Narx-foyda koeffitsiyenti TRC (Tejon Ranch)|UPXI (Upexi Corp) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori BBCP (Concrete Pumping Holdings, Inc.)|Kompaniya qiymatining sof foydaga nisbati PRTC|NL - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Mercer International Inc.|Largo Inc. (LGO) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Great Elm Group, Inc.|VATE (innovatecorp.com) - P/E multiplikatori|MGLD: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Star Equity (STRR)|United-Guardian (UG) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati heartcore.co.jp HTCR|NXPL: Narx-foyda multiplikatori|MWYN - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati PLAG|DSS Inc (DSS) - Narxning foydaga nisbati|Narx-foyda multiplikatori ARBB|GBR (New Concept Energy) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Ucommune Corp UK|P/E multiplikatori HE|Narxning foydaga nisbati AULT (Ault Alliance, Inc.)|Narxning foydaga nisbati CSW Industrials Inc CSWI|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Ideanomics Corp|Jewett-Cameron Trading - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati SPLP|VGR: P/E multiplikatori|VINO (Gaucho Group Holdings Inc.) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti RHLDV